Protected Indazole Boronic
Acid Pinacolyl Esters: Facile Syntheses and Studies of
Reactivities in Suzuki-Miyaura Cross-Coupling and Hydroxydeboronation
Reactions

François Crestey; Elodie Lohou; Silvia Stiebing; Valérie Collot; Sylvain Rault

doi:10.1055/s-0028-1087922

LETTER

Protected Indazole Boronic Acid Pinacolyl Esters: Facile Syntheses and Studies of Reactivities in Suzuki-Miyaura Cross-Coupling and Hydroxydeboronation Reactions

François Crestey, Elodie Lohou, Silvia Stiebing, Valérie Collot*, Sylvain Rault
Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Centre d’Études et de Recherche sur le Médicament de Normandie (CERMN), UPRES EA-4258, FR CNRS INC3M, Boulevard Becquerel, 14032 Caen Cedex, France
Fax: +33(2)31931188; e-Mail: valerie.collot@unicaen.fr;

Abstract

All articles of this category

Abstract

The paper describes a rapid and efficient synthesis for the isolation of protected indazolylboronic esters. These compounds were synthesized by reaction between prepared protected haloindazoles and bis(pinacolato)diboron. The effects of solvent, temperature, reaction time, and the nature of halogen atom as well as protecting group were investigated. Additionaly, these compounds reacted either with aryl halides in a Suzuki-Miyaura cross-coupling reaction or with hydrogen peroxide in a hydroxydeboronation reaction showing the potential access to new aryl and hydroxyindazole libraries.

Key words

indazole boronic acid pinacolyl esters - Suzuki-Miyaura cross-coupling reaction - palladium-mediated reaction - protected halo-1H-indazoles - hydroxydeboronation

Full Text

References

References and Notes

<A NAME="RG32908ST-1A">1a</A> Crestey F. Stiebing S. Legay R. Collot V. Rault S. Tetrahedron 2007, 63: 419

<A NAME="RG32908ST-1B">1b</A> Collot V. Bovy PR. Rault S. Tetrahedron Lett. 2000, 41: 9053

<A NAME="RG32908ST-1C">1c</A> Collot V. Dallemagne P. Bovy PR. Rault S. Tetrahedron 1999, 55: 6917

<A NAME="RG32908ST-2A">2a</A> Crestey F. Collot V. Stiebing S. Lohier J.-F. Sopkova-de Oliveira Santos J. Rault S. Tetrahedron Lett. 2007, 48: 2457

<A NAME="RG32908ST-2B">2b</A> Crestey F. Collot V. Stiebing S. Rault S. Synthesis 2006, 3506

<A NAME="RG32908ST-2C">2c</A> Crestey F. Collot V. Stiebing S. Rault S. Tetrahedron 2006, 62: 7772

<A NAME="RG32908ST-2D">2d</A> Witulski B. Azcon JR. Alayrac C. Arnautu A. Collot V. Rault S. Synthesis 2005, 771

<A NAME="RG32908ST-2E">2e</A> Arnautu A. Collot V. Calvo Ros J. Alayrac C. Witulski B. Rault S. Tetrahedron Lett. 2002, 43: 2695

<A NAME="RG32908ST-2F">2f</A> Collot V. Varlet D. Rault S. Tetrahedron Lett. 2000, 41: 4363

<A NAME="RG32908ST-3A">3a</A> Herradura PS. Pendola KA. Guy RK. Org. Lett. 2000, 2: 2019

<A NAME="RG32908ST-3B">3b</A> Chan DMT. Monaco KL. Wang R.-P. Winters MP. Tetrahedron Lett. 1998, 39: 2933

<A NAME="RG32908ST-3C">3c</A> Lam PYS. Clark CG. Saubern S. Adams J. Winters MP. Chan DMT. Combs A. Tetrahedron Lett. 1998, 39: 2941

<A NAME="RG32908ST-4A">4a</A> Kotha S. Lahiri K. Kashinath D. Tetrahedron 2002, 58: 9633

<A NAME="RG32908ST-4B">4b</A> Suzuki A. J. Organomet. Chem. 1999, 576: 147

<A NAME="RG32908ST-4C">4c</A> Miyaura N. Suzuki A. Chem. Rev. 1995, 95: 2457

<A NAME="RG32908ST-5">5</A> Webb KS. Levy D. Tetrahedron Lett. 1995, 36: 5117

<A NAME="RG32908ST-6">6</A> Salzbrunn S. Simon J. Prakash GKS. Petasis NA. Olah GA. Synlett 2000, 1485

<A NAME="RG32908ST-7">7</A> Thiebes C. Prakash GKS. Petasis NA. Olah GA. Synlett 1998, 141

<A NAME="RG32908ST-8">8</A> Urawa Y. Ogura K. Tetrahedron Lett. 2002, 44: 271

<A NAME="RG32908ST-9">9</A> Petasis NA. Goodman A. Zavialov IA. Tetrahedron 1997, 53: 16463

<A NAME="RG32908ST-10A">10a</A> Hall DG. Boronic Acids - Preparation and Applications in Organic Synthesis Wiley-VCH; Weinheim: 2005.

<A NAME="RG32908ST-10B">10b</A> Chincilla R. Najera C. Yus M. Chem. Rev. 2004, 104: 2667

<A NAME="RG32908ST-11">11</A> For a recent review on heterocyclic boronic acids, see: Tyrell E. Brookes P. Synthesis 2003, 469

For the main references at this time to obtain 4-indazolyl-boronic acids and esters, see:

<A NAME="RG32908ST-12A">12a</A> Folkes AJ. Ahmadi K. Alderton WK. Alix S. Baker ST. Box G. Chuckowree IS. Clarke PA. Depledge P. Eccles SA. Friedman LS. Hayes A. Hancox TC. Kugendradas A. Lensun L. Moore P. Olivero AG. Pang J. Patel S. Pergl-Wilson GH. Raynaud FI. Robson A. Saghir N. Salphati L. Sohal S. Ultsch MH. Valenti M. Wallweber HJA. Wan NC. Wiesmann C. Workman P. Zhyvoloup A. Zvelebil MJ. Shuttleworth S. J. Med. Chem. 2008, 51: 5522

<A NAME="RG32908ST-12B">12b</A> Chuckowree I, Folkes A, Hancox T, and Shuttleworth S. inventors; WO 07129161. ; Chem. Abstr. 2007, 147, 541901

<A NAME="RG32908ST-12C">12c</A> Shuttleworth SJ, Folkes AJ, Chuckowree IS, Wan NC, Hancox TC, Baker SJ, Sohal S, and Latif MA. inventors; WO 06046040. ; Chem. Abstr. 2006, 144, 450724

<A NAME="RG32908ST-12D">12d</A> Yoon T, Yuan J, Lee K, Maynard GD, and Liu N. inventors; WO 06004589. ; Chem. Abstr. 2006, 144, 128985

<A NAME="RG32908ST-12E">12e</A> Lee K, Yuan J, Maynard GD, Hutchison A, and Mitchell S. inventors; WO 05110991. ; Chem. Abstr. 2005, 144, 6683

For the main references at this time to obtain 5-indazolyl-boronic acids and esters, see:

<A NAME="RG32908ST-13A">13a</A> Alberti MJ, and Jung DK. inventors; WO 06044753. ; Chem. Abstr. 2006, 144, 432843

<A NAME="RG32908ST-13B">13b</A> Yamashita DS, Lin H, and Wang W. inventors; WO 05085227. ; Chem. Abstr. 2005, 143, 306183

<A NAME="RG32908ST-13C">13c</A> Hagihara M, Komori K.-I, Sunamoto H, Nishida H, Matsugi T, Nakajima T, Hatano M, Kido K, and Hara H. inventors; WO 05035506. ; Chem. Abstr. 2005, 142, 411353

<A NAME="RG32908ST-13D">13d</A> McAlpine IJ, Deal JG, Johnson MC, Kephart SE, Park JY, Romines WH, and Tikhe JG. inventors; US 05090529. ; Chem. Abstr. 2005, 142, 430272

<A NAME="RG32908ST-13E">13e</A> Shoda M, and Kuriyama H. inventors; WO 03070686. ; Chem. Abstr. 2003, 139, 214465

For the main references at this time to obtain 6-indazolyl-boronic acids and esters, see:

<A NAME="RG32908ST-14A">14a</A> Frazee JS, Hammond M, Kano K, Manns S, Nakamura H, Thompson SK, and Washburn DG. inventors; WO 06063167. ; Chem. Abstr. 2006, 145, 62865

<A NAME="RG32908ST-14B">14b</A> Lu T, Thieu TV, Player MR, Lee Y.-K, Parks DJ, Markotan TP, Pan W, and Milkiewicz KL. inventors; WO 06047415. ; Chem. Abstr. 2006, 144, 450703

<A NAME="RG32908ST-14C">14c</A> Bamborough P, Campos SA, Patel VK, Swanson S, and Walker AL. inventors; WO 05073189. ; Chem. Abstr. 2005, 143, 211906

For the main references at this time about 7-indazolyl-boronic acids and esters, see:

<A NAME="RG32908ST-15A">15a</A> Shipps GW, Cheng CC, Huang X, Fischmann TO, Duca JS, Richards M, Zeng H, Sun B, Reddy PA, Wong TT, Tadikonda PK, Siddiqui MA, Labroli MM, Poker C, and Guzi TJ. inventors; WO 08054702. ; Chem. Abstr. 2008, 148, 552346

<A NAME="RG32908ST-15B">15b</A> Kelly M, Lee Y, Liu B, Fujimoto T, Freundlich J, Dorsey BD, Flynn GA, and Husain A. inventors; US 06270686. ; Chem. Abstr. 2006, 146, 7835

<A NAME="RG32908ST-16">16</A> Boulouard M. Schumann-Bard P. Butt-Gueulle S. Lohou E. Stiebing S. Collot V. Rault S. Bioorg. Med. Chem. Lett. 2007, 17: 3177

<A NAME="RG32908ST-17">17</A> Kania RS, Bender SL, Borchardt AJ, Braganza JF, Cripps SJ, Hua Y, Johnson MD, Johnson TO, Luu HT, Palmer CL, Reich SH, Tempczyk-Russell AM, Teng M, Thomas C, Varney MD, and Wallace MB. inventors; WO 0102369. ; Chem. Abstr. 2001, 134, 100864

<A NAME="RG32908ST-18">18</A> Gérard A.-L. Bouillon A. Mahatsekake C. Collot V. Rault S. Tetrahedron Lett. 2006, 47: 4665

<A NAME="RG32908ST-19">19</A> Primas N. Mahatsekake C. Bouillon A. Lancelot J.-C. Sopkova-de Oliveira Santos J. Lohier J.-F. Rault S. Tetrahedron 2008, 64: 4596

<A NAME="RG32908ST-20">20</A> Young MB. Barrow JC. Glass KL. Lundell GF. Newton CL. Pellicore JM. Rittle KE. Selnick HG. Stauffer KJ. Vacca JP. Williams PD. Bohn D. Clayton FC. Cook JJ. Krueger JA. Kuo LC. Lewis SD. Lucas BJ. McMasters DR. Miller-Stein C. Pietrak BL. Wallace AA. White RB. Wong B. Yan Y. Nantermet PG. J. Med. Chem. 2004, 47: 2995

For example, see:

<A NAME="RG32908ST-21A">21a</A> Jiang Q. Ryan M. Zhichkin P.
J. Org. Chem. 2007, 72: 6618

<A NAME="RG32908ST-21B">21b</A> Lee IYC. Jung MH. Lim H.-J. Lee HW. Heterocycles 2005, 65: 2505

<A NAME="RG32908ST-21C">21c</A> Organ MG. Bilokin YV. Bratovanov S. J. Org. Chem. 2002, 67: 5176

<A NAME="RG32908ST-21D">21d</A> Schinazi RF. Prusoff WH. J. Org. Chem. 1985, 50: 841

<A NAME="RG32908ST-22A">22a</A> Voisin A.-S. Bouillon A. Lancelot J.-C. Rault S. Tetrahedron 2005, 61: 1417

<A NAME="RG32908ST-22B">22b</A> Bouillon A. Lancelot J.-C. Sopkova-de Oliveira Santos J. Collot V. Bovy PR. Rault S. Tetrahedron 2003, 59: 10043 ; and references cited therein

<A NAME="RG32908ST-23">23</A> Ishiyama T. Murata M. Miyaura N. J. Org. Chem. 1995, 60: 7508

<A NAME="RG32908ST-24">24</A> Reich SH, Bleckman TM, Kephart SE, Romines WH, and Wallace MB. inventors; WO 01053268. ; Chem. Abstr. 2001, 135: 137505

Typical Experimental Procedure for the Synthesis of Indazolylboronic Esters
To a solution of 1-(4-bromoindazol-1-yl)ethanone (3a, 1.5 g, 6.3 mmol) in 1,4-dioxane (25 mL) were added successively bis(pinacolato)diboron (1.8 g, 7.2 mmol, 1.15 equiv) and KOAc (2.8 g, 23.8 mmol, 4.6 equiv) at r.t. The reaction mixture was degassed under vacuum with argon replacement three times, then PdCl₂ ₍dppf)-CH₂Cl₂ (0.3 g, 0.5 mmol, 0.08 equiv) was added, and the degassing procedure was repeated twice. The reaction was heated under reflux conditions for 15 min then concentrated in vacuo. After the addition of EtOAc, the organic layer was washed successively with H₂O and brine, dried over MgSO₄, and the solvent evaporated in vacuo. The crude material was purified by flash column chromatography on SiO₂ (EtOAc-cyclohexane, 1:3) to give 1-[4-(4,4,5,5-tetramethyl[1,3,2]-
dioxaborolan-2-yl)indazol-1-yl)ethanone (7a); yield 1.8 g (98%); pink solid; mp 128 ˚C. TLC: R _f = 0.6 (EtOAc-cyclohexane, 1:4). IR (KBr): 2976, 1713, 1601, 1415, 1349, 1325, 1174, 1151, 932, 756 cm^-¹. ^¹H NMR (400 MHz, CDCl₃): δ = 1.42 (s, 12 H), 2.80 (s, 3 H), 7.55 (t, J = 8.3 Hz, 1 H), 7.82 (d, J = 7.1 Hz, 1 ), 8.54 (d, J = 7.1 Hz, 1 H), 8.55 (s, 1 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 23.1, 25.0, 84.2, 118.3, 128.6, 130.6, 132.0, 138.3, 141.7, 171.1. MS (EI): m/z (%) = 286 (53) [M⁺], 244 (100), 243 (39), 229 (14), 158 (70), 145 (34), 144 (68), 134 (67). Anal. Calcd for C₁₅H₁₉BN₂O₃: C, 62.96; H, 6.69; N, 9.79. Found: C, 62.39; H, 6.48; N, 9.23.

For Suzuki-Miyaura cross-coupling reactions using K₃PO₄ as base in DMF, see:

<A NAME="RG32908ST-26A">26a</A> Cailly T. Fabis F. Rault S. Tetrahedron 2006, 62: 5862

<A NAME="RG32908ST-26B">26b</A> Watanabe T. Miyaura N. Suzuki A. Synlett 1992, 207

For Suzuki-Miyaura cross-coupling reactions using Na₂CO₃ or Cs₂CO₃ as base in dioxane, see:

<A NAME="RG32908ST-27A">27a</A> Song YS. Lee Y.-J. Kim BT. Heo J.-N. Tetrahedron Lett. 2006, 47: 7427

<A NAME="RG32908ST-27B">27b</A> Heo Y. Song YS. Kim BT. Heo J.-N. Tetrahedron Lett. 2006, 47: 3091

<A NAME="RG32908ST-27C">27c</A> Littke AF. Fu GC. Angew. Chem. Int. Ed. 1999, 37: 3387

7-(4-Methoxyphenyl)-1-(tetrahydro-2 H -pyran-2-yl)-1 H -indazole (17)
Yield 0.3 g (73%); white solid. TLC: R _f = 0.1 (EtOAc-cyclohexane, 1:10). IR (KBr): 3428, 2932, 1611, 1497, 1245, 1078, 1032, 824 cm^-¹. ^¹H NMR (400 MHz, CDCl₃):
δ = 1.37-1.42 (m, 2 H), 1.76-1.78 (m, 1 H), 1.90-1.95 (m,
1 H), 2.56-2.58 (m, 1 H), 2.91-2.96 (m, 1 H), 3.74-3.80 (m, 1 H), 3.91 (s, 3 H), 4.04-4.07 (m, 1 H), 5.00 (dd, J = 12.7, 2.2 Hz, 1 H), 7.02 (dd, J = 7.3, 1.4 Hz, 2 H), 7.18-7.19 (m, 2 H), 7.23-7.26 (m, 2 H), 7.64-7.70 (m, 1 H), 8.12 (s, 1 H). MS (EI): m/z (%) = 308 (22) [M⁺], 224 (100), 209 (26), 192 (2), 182 (8), 154 (7), 85 (8). Anal. Calcd for C₁₉H₂₀N₂O₂: C, 74.00; H, 6.54; N, 9.08. Found: C, 74.30; H, 6.74; N, 9.28.

<A NAME="RG32908ST-29">29</A> Schumann P. Collot V. Hommet Y. Gsell W. Dauphin F. Sopkova J. McKenzie ET. Duval D. Boulouard M. Rault S. Bioorg. Med. Chem. Lett. 2001, 11: 1153

The use of Oxone^® (2KHSO₅-KHSO₄-K₂SO₄) as oxidative reagent in the presence of Na₂CO₃ in a mixture of H₂O-acetone (1:1) at 0 ˚C led to the desired compounds but in lower yields.